Agnieszka Podgorska - Publications

The Clinical Significance of CRNDE Gene Methylation, Polymorphisms, and CRNDEP Micropeptide Expression in Ovarian Tumors.

Journal: International journal of molecular sciences

Published: April 28, 2024

Two sisters diagnosed with familial paraganglioma syndrome type 1 (FPGL1) and multiple endocrine neoplasia type 2A (MEN2A).

Journal: World journal of surgical oncology

Published: February 28, 2024

Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: May 13, 2020

BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.

Journal: Journal of the National Cancer Institute

Published: February 02, 2020

rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.

Journal: International journal of molecular sciences

Published: July 01, 2018

Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells.

Journal: Gynecologic oncology

Published: July 28, 2016

The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.

Journal: Oncotarget

Published: May 18, 2016

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients.

Journal: Oncotarget

Published: June 18, 2015

Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.

Journal: Orphanet journal of rare diseases

Published: October 13, 2014

The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues.

Journal: PloS one

Published: February 09, 2014

Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.

Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists

Published: December 31, 2013

p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.

Journal: Cancer biology & therapy

Published: September 12, 2013